Pathogenesis of multi-organic failure in autoimmune diseases

被引:12
作者
Amaral, M. C.
Alves, J. Delgado [1 ]
机构
[1] Fac Med Sci, Dept Pharmacol, P-1169056 Lisbon, Portugal
关键词
Multi-organic failure; Macrophage activation syndrome; Anti-CD28; antibody; MACROPHAGE ACTIVATION SYNDROME; INFLAMMATION; COAGULATION; ARTHRITIS; DISORDERS; RECEPTORS; CELL;
D O I
10.1016/j.autrev.2009.01.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Multi-organic failure in the context of autoimmune diseases is a multi-factorial condition where different pathways concur to produce a global system breakdown. Some of these pathways include the coagulation, fibrinolysis, kinin and complement cascades which in normal conditions work together to provide a comprehensive response to injury. In pathologic conditions these regulatory mechanisms are replaced by positive feed-back loops. The common response pattern is the activation of the immune system via endothelium activation. Furthermore, these different plasma-driven mechanisms may induce standardised endothelial cell responses of which the most relevant are the activation of p38, JNK NF-kappa beta and IRF-3 pathways. In this paper we review the common points between these major pathways and how they become activated, contributing to a global clinical picture. We present two examples of apparently different clinical settings, caused by the same global dysfunction: the Macrophage Activation Syndrome and the iatrogenic "cytokine storm" triggered by the administration of anti-CD28 monoclonal antibody TGN1412 in a phase 1 trial. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:525 / 528
页数:4
相关论文
共 21 条
[1]   Toll-like receptors: critical proteins linking innate and acquired immunity [J].
Akira, S ;
Takeda, K ;
Kaisho, T .
NATURE IMMUNOLOGY, 2001, 2 (08) :675-680
[2]   Macrophage activation syndrome in rheumatic disease: What is the role of the antigen presenting cell? [J].
Behrens, Edward M. .
AUTOIMMUNITY REVIEWS, 2008, 7 (04) :305-308
[3]  
BERG M, 2008, J LEUKOCYTE BIOL, V83, P1
[4]   Molecular genetics of the fibrinolytic and coagulation systems in haemostasis, thrombogenesis, restenosis and atherosclerosis [J].
Carmeliet, P ;
Collen, D .
CURRENT OPINION IN LIPIDOLOGY, 1997, 8 (02) :118-125
[5]   Factor Xa as an interface between coagulation and inflammation - Molecular mimicry of factor Xa association with effector cell protease receptor-1 induces acute inflammation in vivo [J].
Cirino, G ;
Cicala, C ;
Bucci, M ;
Sorrentino, L ;
Ambrosini, G ;
DeDominicis, G ;
Altieri, DC .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (10) :2446-2451
[6]  
DeBenedetti F, 1997, BRIT J RHEUMATOL, V36, P581
[7]   Biologic basis for interleukin-1 in disease [J].
Dinarello, CA .
BLOOD, 1996, 87 (06) :2095-2147
[8]  
Favara BE, 1997, MED PEDIATR ONCOL, V29, P157, DOI 10.1002/(SICI)1096-911X(199709)29:3<157::AID-MPO1>3.0.CO
[9]  
2-C
[10]   CD28 superagonists:: Mode of action and therapeutic potential [J].
Hünig, T ;
Dennehy, K .
IMMUNOLOGY LETTERS, 2005, 100 (01) :21-28